CISD2 and hepatocellular carcinoma: Silencing CISD2 reduced the cell proliferation of resistant hepatocellular carcinoma (HCC) cells by increasing ferroptosis, while inhibiting both CISD2 and BECN1 decreased ferroptosis in HCC cells (Li et al., 2021).